Real-world experience in initiation of treatment with the selective cardiomyosin inhibitor mavacamten in an outpatient clinic cohort during the 12-week titration period.

Autor: Becker F; Department of Medicine I, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Munich, Munich Heart Alliance (MHA), 80802, Munich, Germany.; Member of the European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart), Munich, Germany., Novotny J; Department of Medicine I, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Munich, Munich Heart Alliance (MHA), 80802, Munich, Germany., Jansen N; Department of Medicine I, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany., Clauß S; Department of Medicine I, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Munich, Munich Heart Alliance (MHA), 80802, Munich, Germany.; Member of the European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart), Munich, Germany.; Institute of Surgical Research at the Walter-Brendel-Centre of Experimental Medicine University Hospital, LMU Munich, Munich, Germany.; Interfaculty Center for Endocrine and Cardiovascular Disease Network Modelling and Clinical Transfer (ICONLMU), LMU Munich, Munich, Germany., Möller-Dyrna F; Department of Medicine I, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany., Specht B; Department of Medicine I, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany., Orban M; Department of Medicine I, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Munich, Munich Heart Alliance (MHA), 80802, Munich, Germany., Massberg S; Department of Medicine I, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Munich, Munich Heart Alliance (MHA), 80802, Munich, Germany.; Interfaculty Center for Endocrine and Cardiovascular Disease Network Modelling and Clinical Transfer (ICONLMU), LMU Munich, Munich, Germany., Kääb S; Department of Medicine I, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany. stefan.kaab@med.uni-muenchen.de.; DZHK (German Center for Cardiovascular Research), Partner Site Munich, Munich Heart Alliance (MHA), 80802, Munich, Germany. stefan.kaab@med.uni-muenchen.de.; Member of the European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart), Munich, Germany. stefan.kaab@med.uni-muenchen.de.; Interfaculty Center for Endocrine and Cardiovascular Disease Network Modelling and Clinical Transfer (ICONLMU), LMU Munich, Munich, Germany. stefan.kaab@med.uni-muenchen.de., Reichart D; Department of Medicine I, LMU University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.; DZHK (German Center for Cardiovascular Research), Partner Site Munich, Munich Heart Alliance (MHA), 80802, Munich, Germany.; Member of the European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart), Munich, Germany.; Interfaculty Center for Endocrine and Cardiovascular Disease Network Modelling and Clinical Transfer (ICONLMU), LMU Munich, Munich, Germany.

Publikováno v: Clinical research in cardiology : official journal of the German Cardiac Society [Clin Res Cardiol] 2024 Oct 08. Date of Electronic Publication: 2024 Oct 08.

Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers

Autor: Metzger, W.G, Mansouri, E, Kronawitter, M, Diescher, S, Soerensen, M, Hurwitz, R, Bumann, D, Aebischer, T, von Specht, B.-U, Meyer, T.F

Publikováno v: In Vaccine 2004 22(17):2273-2277

Venμs geometric image quality commissioning.

Autor: Binet, R., De Lussy, F., Languille, F., Rolland, A., Gamet, P., Raynaud, J.-L., Specht, B.

Publikováno v: Proceedings of SPIE; 8/1/2018, Vol. 10785, p1-13, 13p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Receptor assay based on surface plasmon resonance for the assessment of the complex formation activity of cyclosporin A and its metabolites

Autor: B. Vollenbroeker, Michael Erren, Spener F, Bartetzko N, Helge Hohage, Manfred Fobker, Specht B

Publikováno v: Int. Journal of Clinical Pharmacology and Therapeutics. 41:248-260

Objective: A new automated receptor assay has been used to determine the complex formation activity of cyclosporin A (CsA) and its metabolites in whole blood. Methods: CsA in vivo forms a complex with cyclophilin A and calcineurin leading to an inhib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::348e3135606f9d8e806d772ab6153865
https://doi.org/10.5414/cpp41248